JNJ vs EW
By Alex · Tickerpine
Johnson & Johnson vs Edwards Lifesciences Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | EW |
|---|---|---|
| Price | $254.66 | $90.78 |
| Market cap | $613.02B | $52.27B |
| P/E ratio | 29.5 | 49.1 |
| ROE | 26.42% | 10.46% |
| Profit margin | 21.83% | 17.39% |
| Revenue growth | 9.90% | 16.70% |
| Dividend yield | 2.10% | — |
| Beta | 0.26 | 0.87 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs EW in plain English
- JNJ is the bigger company — about 11.7× the market cap of EW.
- JNJ is cheaper on earnings (P/E 29.5 vs 49.1).
- JNJ earns a higher return on equity (26% vs 10%).
- EW is growing revenue faster (17% vs 10%).
- JNJ pays a dividend (2.10%) while the other effectively doesn't.
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
EW return calculator
See what $1,000 in Edwards Lifesciences Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.